… of I/R injury. Herein, we analytically review the pathological mechanism and targeted treatment
of ferroptosis in I/R … of myocardial I/R injury, cerebral I/R injury, and ischemic renal injury. …

… mechanism and targeted therapeutic strategies of ferroptosis in I/R … on ferroptosis in I/R injury,
including ferroptosis regulatory … the therapeutic application of ferroptosis regulators, hoping …

… ferroptosis is a major driver of injury occurring in myocardial infarction and can be a promising
target … However, we have to be aware of the advantage and disadvantage of ferroptosis …

… as a new therapeutic target for the management of I/R injury. This review … of ferroptosis and
discusses its relationship with I/R injury, as well as potential treatment strategies targeting it. …

… the metabolic regulatory mechanisms of ferroptosis and the relationship between ferroptosis
and myocardial infarction as well as myocardial ischemia/reperfusion injuries, which might …

… the pathological mechanisms and therapeutic targets of ferroptosis in IRI. … in ferroptosis
pathogenesis, ferroptosis evidence in organ IRIs, and associated potential therapeutic targets …

… of using PDA NPs as a ferroptosis inhibitor for alleviating myocardial I/R injury. This study
may provide new perspectives to address myocardial I/R injury and suggest PDA NPs as a …

… cell damage. Thus, this review emphasized the role of ferroptosis and its inhibition in renal
IRI. Also, Pharmacological modulation of ferroptosis mechanism in renal I/R injury has been …

… an endogenous inhibitor of ACSL4 and regulating kidney ferroptosis. Our results suggest
that miR-20a-5p might be a new therapeutic target for alleviating the damage induced by IRI. …

… damage-associated molecular patterns (DAMPs) after heart transplantation [87]. Therefore,
targeted ferroptosis … heart transplantation after coronary artery reperfusion. Other drugs, such …